Stay updated with breaking news from Caleres Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Caleres (NYSE:CAL – Get Rating) from a hold rating to a buy rating in a research note released on Monday. Separately, Piper Sandler raised shares of Caleres from a neutral rating to an overweight rating and increased their target price for the stock from $26.00 to $35.00 in a research note […]
/PRNewswire/ -- Shoe companies have witnessed C-suite leaders prioritize sustainability, a shift in company cultures showing the footwear industry making giant...
Research Analysts’ upgrades for Monday, April 3rd: Adverum Biotechnologies (NASDAQ:ADVM) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Aptevo Therapeutics (NASDAQ:APVO) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. American Realty Investors (NYSE:ARL) was upgraded by analysts at StockNews.com from a hold rating […]
Shares of Caleres, Inc. (NYSE:CAL – Get Rating) have been given an average rating of “Buy” by the six research firms that are currently covering the stock, Marketbeat reports. Three research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have issued a report on the stock […]
Caleres, Inc. (NYSE:CAL – Get Rating) shares traded down 2.8% during mid-day trading on Wednesday . The company traded as low as $20.86 and last traded at $20.92. 74,882 shares were traded during mid-day trading, a decline of 89% from the average session volume of 688,143 shares. The stock had previously closed at $21.52. Wall […]